NADAG AG

NADAG is a drug discovery company with clinical and preclinical projects. Clinical opportunities derive from internal projects and from the in-licensing of carefully selected opportunities. Core preclinical competences are in cellular biology, pharmacology and chemistry, mostly applied on kinase targets. NADAG has developed a proprietary chemical kinase discovery platform to identify and optimise kinase-directed patentable hits and leads. NADAG focuses on neurodegenerative diseases with significant unmet medical need, such as Parkinson's and Alzheimer's disease. NADAG employs 12 people and is based in Munich, Germany.